Search

Meet Pharmaron, our new member. We spoke with Javier Ruiz Sanz, Associate Director – Business Development.

Meet Universidad de Córdoba, our new member. We spoke with Alejandro Rodríguez Pascual, General Director of Transfer and OTRI.

Statistically significant difference in arrested disease in leriglitazone treated patients when compared to the natural history of the disease

Corify Care has secured €6 million in funding to expand its non-invasive cardiac mapping technology, ACORYS, aimed at improving the diagnosis and treatment of arrhythmias.

With an investment of nearly 30 million euros, Kadans will include quality workspaces, with Breeam certification for sustainable building, together with common areas and elements that foster the

The Eugin Group, from its Basic Research Centre at the Barcelona Science Park, is leading a consortium of 15 public and private European institutions in the development of the IMPLANTEU project. This

VIVEbiotech, a company specializing in lentiviral vectors for gene and cell therapies, has received an investment from Ampersand Capital Partners to expand its manufacturing and development capacity

“Decision to grant” communication in Russia

The conference highlighted the importance of planning funding to ensure the survival of spin-offs and the development of their innovative solutions.

The event, held at the Gran Teatro CaixaBank Príncipe Pío in Madrid, brought together more than 200 attendees, with strong institutional representation.

"Testicular Toxicity Assessment using Zebrafish" and "Validation and Qualification of New Alternative Methods (NAMs) for human safety and toxicity testing" have been the topics presented.

Financing led by TCGX, including new investment from TPG, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital (a Citadel company), and Logos Capital, with participation from all

BCN HEALTH has published the study ‘Relationship between a diagnosis of kidney failure and heart diseases in patients with hyperkalemia’, in the ‘Journal of Medical Economics’, an international

The state of the bioeconomy in Spain was analyzed during a debate sponsored by the European project ShapingBio at the fifth edition of the Green Innovation Forum.

Meet SIMBIONTE, our new member. We spoke with Manuel Esbrí Ramos, co-founder.

LeishGenApp and LeishGenR are Nano1Health’s cutting-edge solutions for detecting drug resistance biomarkers in Leishmania infantum, tailored to meet the needs of researchers, veterinarians, and

The Green Innovation Forum provided a space for creating new business and investment opportunities, facilitated by its partnering platform, which enabled over 200 one-on-one meetings.

The company, based in Salamanca, expects to triple its workforce in the next two years. This is when the construction of a 90,000 square meter complex will be completed, allowing the company to